185 related articles for article (PubMed ID: 21818622)
1. Early effects of erythropoietin on serum hepcidin and serum iron bioavailability in healthy volunteers.
Lainé F; Laviolle B; Ropert M; Bouguen G; Morcet J; Hamon C; Massart C; Westermann M; Deugnier Y; Loréal O
Eur J Appl Physiol; 2012 Apr; 112(4):1391-7. PubMed ID: 21818622
[TBL] [Abstract][Full Text] [Related]
2. Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.
Shoji S; Inaba M; Tomosugi N; Okuno S; Ichii M; Yamakawa T; Kurihara S
Eur J Haematol; 2013 Mar; 90(3):237-44. PubMed ID: 23281632
[TBL] [Abstract][Full Text] [Related]
3. Effects of altitude and recombinant human erythropoietin on iron metabolism: a randomized controlled trial.
Breenfeldt Andersen A; Bonne TC; Bejder J; Jung G; Ganz T; Nemeth E; Olsen NV; Huertas JR; Nordsborg NB
Am J Physiol Regul Integr Comp Physiol; 2021 Aug; 321(2):R152-R161. PubMed ID: 34160288
[TBL] [Abstract][Full Text] [Related]
4. Effect of erythropoietin on hepcidin, DMT1 with IRE, and hephaestin gene expression in duodenum of rats.
Kong WN; Chang YZ; Wang SM; Zhai XL; Shang JX; Li LX; Duan XL
J Gastroenterol; 2008; 43(2):136-43. PubMed ID: 18306987
[TBL] [Abstract][Full Text] [Related]
5. Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.
Zaritsky J; Young B; Wang HJ; Westerman M; Olbina G; Nemeth E; Ganz T; Rivera S; Nissenson AR; Salusky IB
Clin J Am Soc Nephrol; 2009 Jun; 4(6):1051-6. PubMed ID: 19406957
[TBL] [Abstract][Full Text] [Related]
6. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
Mittman N; Sreedhara R; Mushnick R; Chattopadhyay J; Zelmanovic D; Vaseghi M; Avram MM
Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
[TBL] [Abstract][Full Text] [Related]
7. Serum hepcidin levels and muscle iron proteins in humans injected with low- or high-dose erythropoietin.
Robach P; Recalcati S; Girelli D; Campostrini N; Kempf T; Wollert KC; Corbella M; Santambrogio P; Perbellini L; Brasse-Lagnel C; Christensen B; Moutereau S; Lundby C; Cairo G
Eur J Haematol; 2013 Jul; 91(1):74-84. PubMed ID: 23582009
[TBL] [Abstract][Full Text] [Related]
8. Hepcidin is correlated to soluble hemojuvelin but not to increased GDF15 during pregnancy.
Finkenstedt A; Widschwendter A; Brasse-Lagnel CG; Theurl I; Hubalek M; Dieplinger H; Tselepis C; Ward DG; Vogel W; Zoller H
Blood Cells Mol Dis; 2012 Apr; 48(4):233-7. PubMed ID: 22365732
[TBL] [Abstract][Full Text] [Related]
9. Hepcidin as a potential biomarker for blood doping.
Leuenberger N; Bulla E; Salamin O; Nicoli R; Robinson N; Baume N; Saugy M
Drug Test Anal; 2017 Jul; 9(7):1093-1097. PubMed ID: 27758046
[TBL] [Abstract][Full Text] [Related]
10. Ferroportin in monocytes of hemodialysis patients and its associations with hepcidin, inflammation, markers of iron status and resistance to erythropoietin.
Eleftheriadis T; Pissas G; Remoundou M; Filippidis G; Antoniadi G; Oustampasidou N; Liakopoulos V; Stefanidis I
Int Urol Nephrol; 2014 Jan; 46(1):161-7. PubMed ID: 23860963
[TBL] [Abstract][Full Text] [Related]
11. Effects of iron supplementation on serum hepcidin and serum erythropoietin in low-birth-weight infants.
Berglund S; Lönnerdal B; Westrup B; Domellöf M
Am J Clin Nutr; 2011 Dec; 94(6):1553-61. PubMed ID: 22071701
[TBL] [Abstract][Full Text] [Related]
12. Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients.
Kato A; Tsuji T; Luo J; Sakao Y; Yasuda H; Hishida A
Am J Nephrol; 2008; 28(1):115-21. PubMed ID: 17943020
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics meta-analysis of recombinant human erythropoietin in healthy subjects.
Olsson-Gisleskog P; Jacqmin P; Perez-Ruixo JJ
Clin Pharmacokinet; 2007; 46(2):159-73. PubMed ID: 17253886
[TBL] [Abstract][Full Text] [Related]
14. Iron as the key modulator of hepcidin expression in erythroid antibody-mediated hypoplasia.
Fernandes JC; Garrido P; Ribeiro S; Rocha-Pereira P; Bronze-da-Rocha E; Belo L; Costa E; Reis F; Santos-Silva A
Biomed Res Int; 2014; 2014():421304. PubMed ID: 25580431
[TBL] [Abstract][Full Text] [Related]
15. Reduction of serum hepcidin by hemodialysis in pediatric and adult patients.
Zaritsky J; Young B; Gales B; Wang HJ; Rastogi A; Westerman M; Nemeth E; Ganz T; Salusky IB
Clin J Am Soc Nephrol; 2010 Jun; 5(6):1010-4. PubMed ID: 20299375
[TBL] [Abstract][Full Text] [Related]
16. Changes in hepcidin and reticulocyte hemoglobin equivalent levels in response to continuous erythropoietin receptor activator administration in hemodialysis patients: a randomized study.
Kakimoto-Shino M; Toya Y; Kuji T; Fujikawa T; Umemura S
Ther Apher Dial; 2014 Oct; 18(5):421-6. PubMed ID: 24456328
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin.
Ashby DR; Gale DP; Busbridge M; Murphy KG; Duncan ND; Cairns TD; Taube DH; Bloom SR; Tam FW; Chapman R; Maxwell PH; Choi P
Haematologica; 2010 Mar; 95(3):505-8. PubMed ID: 19833632
[TBL] [Abstract][Full Text] [Related]
18. Relationship of serum haemojuvelin and hepcidin levels with iron level and erythropoietin requirement in prevalent hepatitis C virus positive haemodialysis patients.
El Said HW; Abou Seif KH; Ahmed YS; Abou Elleil HA; El Said TW; Behairy MA; Mohamed MM; Ahmed FA
Nephrology (Carlton); 2018 Apr; 23(4):323-330. PubMed ID: 28130911
[TBL] [Abstract][Full Text] [Related]
19. Hepcidin and inflammatory bowel disease: dual role in host defence and iron homoeostasis.
Arnold J; Sangwaiya A; Bhatkal B; Geoghegan F; Busbridge M
Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):425-9. PubMed ID: 19262400
[TBL] [Abstract][Full Text] [Related]
20. Randomized, double-blind, placebo-controlled trial of an iron-fortified food product in female soldiers during military training: relations between iron status, serum hepcidin, and inflammation.
Karl JP; Lieberman HR; Cable SJ; Williams KW; Young AJ; McClung JP
Am J Clin Nutr; 2010 Jul; 92(1):93-100. PubMed ID: 20444958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
